Net Income

With burnout and financial woes plaguing healthcare, Altera Digital Health bets on advanced AI to ease burdens and restore the human touch at HIMSS26.

As AI reshapes software, Tricentis is taking its Transform conference global, pushing a new paradigm of 'agentic quality engineering.' Here's what it means.

L.E.K. Consulting's new report reveals fierce competition, faster trend cycles, and the widening gap between winners and losers in the apparel industry.

As shadow AI and autonomous agents create huge risks, Teramind's new platform offers total visibility to help firms innovate without sacrificing security.

As SIGA prepares to unveil its 2025 financials, investors are focused on the future of its Tpoxx contracts and its role in global biodefense strategy.

With promising clinical data for its heart disease treatments, Lexeo Therapeutics aims to capture investor attention at the upcoming Leerink conference.

In its first year post-Comcast, Versant Media battles linear TV declines with a bold digital pivot, a new dividend, and a $1 billion stock buyback.

A significant order for critical Tomahawk missile parts sends Mobix Labs' stock soaring, highlighting the firm's key role in a surging defense market.

Facing declining revenue, Goodfood adds restructuring and digital experts to its board. Can this shake-up revive the Canadian meal-kit pioneer?

A new report shows fraud fears in private credit are soaring, fueled by AI and bankruptcies, but data reveals a different story for secured lenders.

The digital asset giant is delisting from Toronto to streamline costs, a move that reshapes its buyback plan and how Canadian investors trade its stock.

Creality's new Sermoon P1 combines standalone processing and multi-mode lasers, offering industrial-grade 3D scanning at a disruptive price point.

A novel inhaled RNA therapy for a specific group of cystic fibrosis patients gains EMA fast-track status, promising accelerated access to new treatment.

With its SMA drug stalled by a factory inspection, Scholar Rock secures major financing and signals a clear path to a transformative market debut in 2026.

A new trial for a cell therapy targeting a rare eye disease offers hope, driven by a patient-advocate's journey and with potential to treat common AMD.

With 74,000 UK mothers losing jobs annually, a new alliance between Momcozy and AllBright uses tech and advocacy to turn the motherhood penalty into power.

A new report reveals Canadians are overwhelmed by scams, making them vulnerable to AI-driven fraud. Is a national strategy enough to fight back?

A major renewal with a 30M-client bank highlights the industry's shift to biometrics, boosting BIO-key's finances and solidifying its market niche.

The caller ID giant is expanding its ad business into Africa, MENA, and Asia, a move to diversify revenue and tap into booming mobile-first economies.

A novel CRISPR-based therapy safely targets deadly E. coli in the gut, showing promise in the fight against antibiotic resistance and for protecting cancer patients.